Cargando…

Development and External Validation of a Nomogram for Predicting Survival in Patients With Stage IA Non-small Cell Lung Cancer ≤2 cm Undergoing Sublobectomy

Background: Postoperative prognosis of early stage non-small cell lung cancer (NSCLC) undergoing sublobectomy is heterogeneous. Therefore, we sought to construct a novel survival prediction model for stage IA NSCLC ≤2 cm undergoing sublobectomy. Methods: Based on the data from the Surveillance, Epid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wo, Yang, Yang, Hongxia, Zhang, Yinling, Wo, Jinshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917609/ https://www.ncbi.nlm.nih.gov/pubmed/31921643 http://dx.doi.org/10.3389/fonc.2019.01385

Ejemplares similares

Sublobectomy for stage IA1‐2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25
por: Qi, Yi‐Fan, et al.
Publicado: (2022)

V7 ENB‐guided thoracoscopic sublobectomy for stage IA synchronous multiple primary lung cancer
por: Wang, Kun, et al.
Publicado: (2022)

Lobectomy Versus Sublobectomy in Stage IIIA/N2 Non-Small Cell Lung Cancer: A Population-Based Study
por: Wang, Suyu, et al.
Publicado: (2021)

Functional Preserving Sublobectomy: A Novel Method for Sublobectomy
por: Zhang, Min, et al.
Publicado: (2021)

Sublobectomy versus Lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study
por: Liu, Yaxin, et al.
Publicado: (2014)

Development and external validation of a dynamic nomogram to predict the survival for adenosquamous carcinoma of the pancreas
por: Ren, Chao, et al.
Publicado: (2022)

Survival analysis and nomogram for pulmonary sarcomatoid carcinoma: an SEER analysis and external validation
por: Wu, Weishuai, et al.
Publicado: (2023)

Survival nomogram for different grades of gastric cancer patients based on SEER database and external validation cohort
por: Hu, Lei, et al.
Publicado: (2022)

Clinical analysis of the impact of sublobectomy on pulmonary function
por: Yang, Haiping, et al.
Publicado: (2017)

Development and External Validation of a Nomogram for Predicting Cancer-Specific Survival of Non-Small Cell Lung Cancer Patients With Ipsilateral Pleural Dissemination
por: Wang, Zhenfan, et al.
Publicado: (2021)

An Externally Validated Nomogram for Predicting Lymph Node Metastasis of Presumed Stage I and II Endometrial Cancer
por: Dong, Yangyang, et al.
Publicado: (2019)

Development and validation of a new stage-specific nomogram model for predicting cancer-specific survival in patients in different stages of colon cancer: A SEER population-based study and external validation
por: Hu, Chenhao, et al.
Publicado: (2022)

External Application of a Nomogram to Predict Survival and Benefit of Peripheral Blood Inflammatory Indexes in Limited-Stage Small Cell Lung Cancer
por: Wei, Lijuan, et al.
Publicado: (2022)

A nomogram to predict prognosis in patients undergoing sublobar resection for stage IA non-small-cell lung cancer
por: Yang, Heli, et al.
Publicado: (2018)

Survival Nomogram for Young Breast Cancer Patients Based on the SEER Database and an External Validation Cohort
por: Huang, Xiao, et al.
Publicado: (2022)

Survival nomogram for high-grade bladder cancer patients after surgery based on the SEER database and external validation cohort
por: Li, Yihe, et al.
Publicado: (2023)

Development and External Validation of a Nomogram to Predict Recurrence-Free Survival After R0 Resection for Stage II/III Gastric Cancer: An International Multicenter Study
por: Lu, Jun, et al.
Publicado: (2020)

Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis
por: Yang, Yong, et al.
Publicado: (2021)

Radiomics Nomogram for Identifying Sub-1 cm Benign and Malignant Thyroid Lesions
por: Wu, Xinxin, et al.
Publicado: (2021)

Lobectomy vs. sublobectomy for stage I non-small-cell lung cancer: a meta-analysis
por: Lv, Fang, et al.
Publicado: (2021)

Development and Validation of a Nomogram for Predicting Survival in Male Patients With Breast Cancer
por: Chen, Siying, et al.
Publicado: (2019)

Adjuvant treatment can improve prognosis in patients with non-small cell lung cancer ≤3 cm after sublobectomy: a propensity score analysis
por: Ma, Haibo, et al.
Publicado: (2021)

Development and validation of a nomogram based on preoperative variables for predicting recurrence‐free survival in stage IA lung adenocarcinoma
por: Xu, Jiaxi, et al.
Publicado: (2023)

Development and Validation of Nomograms to Predict Overall Survival and Cancer-Specific Survival in Patients With Pancreatic Adenosquamous Carcinoma
por: Yang, Zhen, et al.
Publicado: (2022)

Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study
por: Yu, Yue, et al.
Publicado: (2020)

Development and Validation of a CT-Based Radiomics Nomogram for Predicting Postoperative Progression-Free Survival in Stage I–III Renal Cell Carcinoma
por: Zhang, Haijie, et al.
Publicado: (2022)

An external validation of the nocera nomogram: Predicting non-organ confined stage of ≥pT3 in cT1 clear cell renal cell carcinoma
por: Wenzel, Mike, et al.
Publicado: (2022)

Prognostic Nomograms Predicting Survival in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: The First Nomogram Compared With Revised FIGO 2018 Staging System
por: Yang, Xi, et al.
Publicado: (2020)

Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for Identifying Benign and Malignant Breast Lesions of Sub-1 cm
por: Lin, Fan, et al.
Publicado: (2020)

Development and validation of a nomogram to predict cancer-specific survival with unresected cholangiocarcinoma undergoing external radiotherapy
por: Song, Jiazhao, et al.
Publicado: (2023)

Development and validation of a nomogram for predicting survival time and making treatment decisions for clinical stage IA NSCLC based on the SEER database
por: Xu, Bingchen, et al.
Publicado: (2022)

An Externally-Validated Dynamic Nomogram Based on Clinicopathological Characteristics for Evaluating the Risk of Lymph Node Metastasis in Small-Size Non-small Cell Lung Cancer
por: Wu, Yijun, et al.
Publicado: (2020)

Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast
por: Cheng, Yixin, et al.
Publicado: (2023)

Construction and validation of a nomogram to predict overall survival in patients with breast sarcoma
por: Cheng, Yixin, et al.
Publicado: (2022)

Survival after wedge resection versus lobectomy for stage IA second primary NSCLC with previous lung cancer-directed surgery
por: Song, Congkuan, et al.
Publicado: (2022)

A Matched Comparison Study of Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early-stage Nonsmall Cell Lung Cancer
por: Mu, Ju-Wei, et al.
Publicado: (2015)

Nomogram combining clinical and radiological characteristics for predicting the malignant probability of solitary pulmonary nodules measuring ≤ 2 cm
por: Xue, Mengchao, et al.
Publicado: (2023)

Nomograms for intraoperative prediction of lymph node metastasis in clinical stage IA lung adenocarcinoma
por: Li, Feng, et al.
Publicado: (2023)

Survival nomogram for medulloblastoma and multi-center external validation cohort
por: Li, Xiang, et al.
Publicado: (2023)

The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer
por: Liu, Zhao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_odcikcm9ku3t2r5ofnoibib4gh